Fate Therapeutics
FATE
FATE
259 hedge funds and large institutions have $7.73B invested in Fate Therapeutics in 2021 Q1 according to their latest regulatory filings, with 52 funds opening new positions, 90 increasing their positions, 89 reducing their positions, and 36 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more ownership
Funds ownership: →
3% less capital invested
Capital invested by funds: $7.94B → $7.73B (-$215M)
10% less call options, than puts
Call options by funds: $23.3M | Put options by funds: $25.8M
14% less funds holding in top 10
Funds holding in top 10: 14 → 12 (-2)
Holders
259
Holding in Top 10
12
Calls
$23.3M
Puts
$25.8M
Top Buyers
| 1 | +$301M | |
| 2 | +$71.4M | |
| 3 | +$59.7M | |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$57.5M |
| 5 |
BlackRock
New York
|
+$40.6M |
Top Sellers
| 1 | -$90.7M | |
| 2 | -$53.2M | |
| 3 | -$35M | |
| 4 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$29.8M |
| 5 |
GH
Grosvenor Holdings
Chicago,
Illinois
|
-$27.7M |